Bradycardia and B-type natriuretic peptide

International Journal of Cardiology

Volumn 135, Issue 2, 2009, Pages 238-239

  Kováts, Tímea ^a   Tomcsányi, János ^a  

^a St John of God Hospital ^*  (Hungary)

Author keywords

Atrioventricular synchrony; B type natriuretic peptide; BNP; Bradycardia; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; LOSARTAN;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; BRADYCARDIA; DIAGNOSTIC VALUE; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE TENSION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; PACEMAKER; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; BRADYCARDIA; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 67349122612     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.086     Document Type: Article

References (4)

1. Koch A., Zink S., and Dittrich S. Plasma levels of B type natriuretic peptide in children and adolescents with high degree atrioventricular block. Int J Cardiol (2008) IJC-D-07-02665
2. Kovats T., Wettstein A., Nagy E., and Tomcsanyi J. Bradycardia can induce increased serum natriuretic peptide-level. Int J Cardiol 123 (2008) e43-44
3. van den Meiracker A.H., Lameris T.W., van de Ven L.L., and Boomsma F. Increased plasma concentration of natriuretic peptides by selective beta1-blocker bisoprolol. J Cardiovasc Pharmacol 42 (2003) 462-468
4. Wachtell K., Lehto M., Gerdts E., et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 712-719